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Abamectin (ABA) is a macrocyclic lactone of the avermectin family used worldwide as an antiparasitic
agent in farm animals and pets and as the active ingredient of insecticides and nematicides. In this study,
the effects of abamectin on the bioenergetics of mitochondria isolated from rat liver were evaluated.
Mitochondria are responsible for converting the energy released by electron transport and stored as
the binding energy molecule ATP. Xenobiotics that interfere with its synthesis or utilization can be
acutely or chronically toxic. Abamectin (5–25 lM) caused concentration-dependent inhibition of the
respiratory chain without affecting the membrane potential or the activity of enzymes NADH dehydro-
genase or succinate dehydrogenase. This behavior is similar to oligomycin and carboxyatractyloside
and suggests direct action on FoF1-ATPase and/or the adenine nucleotide translocator (ANT). ABA more
pronouncedly inhibited ATPase phosphohydrolase activity in intact, uncoupled mitochondria than in
freeze–thawed disrupted mitochondria. ADP-stimulated depolarization of the mitochondrial membrane
potential was also inhibited by ABA. Our results indicate that ABA interacts more speciﬁcally with the
ANT, resulting in functional inhibition of the translocator with consequent impairment of mitochondrial
bioenergetics. This effect could be involved in the ABA toxicity to hepatocytes.
 2011 Elsevier Ltd.Open access under the Elsevier OA license.1. Introduction
Abamectin (ABA) is obtained by natural fermentation of Strepto-
myces avermitilis, which provides a mixture of avermectins consist-
ing ofP80% of avermectin B1a and 620% avermectin B1b (Agarwal,
1998). B1a and B1b (Fig. 1) have similar biological and toxicological
properties (Hayes and Laws, 1990). Abamectin is currently used in
several countries as a pest control agent in livestock and as an ac-
tive principle of nematicides and insecticides for agricultural use
(Kolar et al., 2008). ABA is highly toxic to insects and may be highly
toxic to mammals (Lankas and Gordon, 1989). Seixas et al. (2006)
reported that ABA poisoning caused the death of 57 calves over
4 years. The authors noted that this number, caused by incorrect
dosage to the animals, might be underestimated because signs of
intoxication vary in intensity and many animals recover quickly.
Despite its restricted use to animals and crops, several cases of
accidental or intentional abamectin poisoning in human also have
been described (Chung et al., 1999; Yang, 2008).
Due to its interposition between the digestive tract and the gen-
eral circulation of the body, the liver has an important role in
metabolism and biotransformation of exogenous substances.
Therefore, it receives large amounts of nutrients and xenobioticsx: +55 18 3821 8208.
Mingatto).
sevier OA license.absorbed through the digestive tract and portal vein, becoming
the target organ of several classes of toxicants and natural or syn-
thetic toxins (Guillouzo, 1998). The most direct mechanism of liver
toxicity, at the cellular and molecular level, is the speciﬁc interac-
tion of the toxicant with a critical cellular component (mitochon-
dria, for example) and subsequent modulation of its function
(Meyer and Kulkarni, 2001).
ABA poisoning can impair the function of hepatocytes. Research
conducted by Hsu et al. (2001) showed elevated levels of the en-
zyme aspartate aminotransferase (AST) in the blood serum of rats
after exposure to ABA by gavage at doses between 1 and 20 mg/kg
body weight. The maximum activity was obtained with a dose of
20 mg/kg of body weight 1 h after ingestion. Eissa and Zidan
(2010), using a commercial product, also observed signs of aba-
mectin liver toxicity, with increased activity of the enzyme AST
in rats treated with doses equivalent to 1/10 or 1/100 of the LD50
(18 mg/kg) in the diet of animals over 30 consecutive days. In addi-
tion, El-Shenawy (2010) undertook a comparative study of the
in vitro toxic action of some insecticides, including ABA at concen-
trations of 10 and 100 lM, on isolated rat hepatocytes. There was a
signiﬁcant increase in alanine aminotransferase (ALT) and aspar-
tate aminotransferase (AST) activity when hepatocytes were incu-
bated for 30 min with either concentration of ABA. This activity
persisted after 120 min, the longest time point for which data
was collected.
Fig. 1. Chemical structures of abamectin components avermectin B1a and B1b.
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their main function is to produce a majority (>90%) of cellular
ATP. The proton motive force, whose major impetus is the mem-
brane potential (Dw) generated by electron transport along the
respiratory chain in the inner mitochondrial membrane, drives
ATP synthesis via oxidative phosphorylation (Mitchell, 1961).
Experimental evidence from our research group indicates that
mitochondria represent a primary target critical for the action of
drugs and toxins (Mingatto et al., 2000, 2007; Garcia et al.,
2010). Here, we addressed the actions of ABA on mitochondrial
bioenergetics by assessing its effect on respiration, membrane po-
tential, ATP levels, activity of mitochondrial respiratory chain en-
zymes, ATPase and ANT in isolated rat liver mitochondria.
2. Materials and methods
2.1. Chemicals
Abamectin, containing 92% avermectin B1a and 8% avermectin
B1b, was kindly supplied by the company Ouroﬁno Agribusiness
(Cravinhos, São Paulo, Brazil). All other reagents were of the high-
est commercially available grade. Dimethyl sulfoxide (DMSO) used
to dissolve abamectin had no effect on the assays. The volume of
DMSO added never exceeded 0.1% of the total volume of medium.
All stock solutions were prepared using glass-distilled deionized
water.
2.2. Animals
Male Wistar rats weighing approximately 200 g were used in
this study. The animals, provenient from the Central Bioterium of
the São Paulo State University, Botucatu, SP, Brazil, were main-
tained with a maximum of four rats per cage under standard labo-
ratory conditions, while water and food were provided ad libitum.
The experimental protocols were approved by the Ethical Commit-
tee for the Use of Laboratory Animals of the Universidade Estadual
Paulista ‘‘Júlio de Mesquita Filho’’, Campus de Dracena.
2.3. Isolation of intact and disrupted rat liver mitochondria
Mitochondria were isolated by standard differential centrifuga-
tion (Pedersen et al., 1978). Rats were sacriﬁced by decapitation,and the liver was immediately removed, sliced into 50 ml of med-
ium containing 250 mM sucrose, 1 mM EGTA, and 10 mM HEPES-
KOH, pH 7.2, and homogenized three times for 15 s at 1-min inter-
vals with a Potter-Elvehjem homogenizer. Homogenate was centri-
fuged at 770g for 5 min, and the resulting supernatant further
centrifuged at 9800g for 10 min. The pellet was suspended in
10 ml of medium containing 250 mM sucrose, 0.3 mM EGTA, and
10 mM HEPES-KOH, pH 7.2 and centrifuged at 4500g for 15 min.
The ﬁnal mitochondrial pellet was suspended in 1 ml of medium
containing 250 mM sucrose and 10 mM HEPES-KOH, pH 7.2 and
was used within 3 h. The mitochondrial protein concentration
was determined by a biuret assay with BSA as the standard (Cain
and Skilleter, 1987).
The disrupted mitochondria were obtained by heat shock treat-
ment after three consecutive cycles of freezing in liquid nitrogen
and thawing in a water bath heated to 37 C. The membrane frag-
ments were kept at 4 C and were used in the assessment of mito-
chondrial enzymatic activity within 3 h.
2.4. Mitochondrial respiration assay
Mitochondrial respiration was monitored using a Clark-type
oxygen electrode (Strathkelvin Instruments Limited, Glasgow,
Scotland, UK), and respiratory parameters were determined
according to Chance and Williams (1955). One milligram of mito-
chondrial protein was added to 1 ml of respiration buffer contain-
ing 125 mM sucrose, 65 mM KCl, and 10 mM HEPES-KOH, pH 7.4,
plus 0.5 mM EGTA and 10 mM K2HPO4, at 30 C. Oxygen consump-
tion was measured using 5 mM glutamate + 5 mM malate, 5 mM
succinate (+2.5 lM rotenone) or 200 lM N,N,N,N-tetramethyl-p-
phenylene diamine (TMPD) + 3 mM ascorbate as respiratory sub-
strates in the absence (state-4 respiration) or the presence of
400 nmol ADP (state-3 respiration).
2.5. Estimation of mitochondrial membrane potential (Dw)
The mitochondrial membrane potential (Dw) was estimated
spectroﬂuorimetrically using model RF-5301 PC Shimadzu ﬂuores-
cence spectrophotometer (Tokyo, Japan) at the 495/586 nm excita-
tion/emission wavelength pair. Safranine O (10 lM) was used as a
probe (Zanotti and Azzone, 1980). Mitochondria (2 mg protein)
energized with 5 mM glutamate + 5 mM malate were incubated
in a medium containing 125 mM sucrose, 65 mM KCl, 10 mM
HEPES-KOH, pH 7.4, and 0.5 mM EGTA (2 ml ﬁnal volume).
2.6. ATP quantiﬁcation
ATP levels were determined using the ﬁreﬂy luciferin–luciferase
assay system (Lemasters and Hackenbrock, 1976). After incubation
in the presence of ABA, the mitochondrial suspension (1 mg pro-
tein/ml) was centrifuged at 9000g for 5 min at 4 C, and the pellet
was treated with 1 ml of ice-cold 1 M HClO4. After centrifugation at
14000g for 5 min at 4 C, 100 ll aliquots of the supernatants were
neutralized with 5 M KOH, suspended in 100 mM TRIS–HCl, pH 7.8
(1 ml ﬁnal volume), and centrifuged at 15000g for 15 min. The
supernatant was worked up with a Sigma/Aldrich assay kit (Cata-
log Number FLAA) according to the manufacturer’s instructions
and measured using a SIRIUS Luminometer (Berthold, Pforzheim,
Germany).
2.7. Mitochondrial ATPase activity
Mitochondrial ATPase activity was measured in intact-uncou-
pled and freeze–thawing-disrupted mitochondria according to
the protocol of Bracht et al. (2003), with modiﬁcations. Intact mito-
chondria (1 mg protein/ml) were incubated in a medium contain-
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Fig. 2. Effect of abamectin on the state-3 respiration rate of glutamate plus malate
(A) and succinate-energized (B) rat liver mitochondria. Assay conditions are
described in Section 2. Values represent the mean ± S.E. mean of three experiments
with different mitochondrial preparations. ⁄⁄Signiﬁcantly different from control
(P < 0.01).
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plus 0.2 mM EGTA and 5 mM ATP for 20 min at 37 C, in the pres-
ence of 1 lM carbonyl cyanide m-chlorophenyl hydrazone (CCCP),
in a ﬁnal volume of 0.5 ml. When disrupted mitochondria were
used as the enzyme source, the medium contained 20 mM TRIS–
HCl (pH 7.4). The reaction was started by the addition of 5 mM
ATP and stopped by the addition of ice-cold 5% trichloroacetic acid.
ATPase activity was evaluated by measuring released inorganic
phosphate, as described by Fiske and Subbarow (1925), at
700 nm using a DU-800 spectrophotometer (Beckman Coulter, Ful-
lerton, CA).
Results were expressed as nmol Pi. min1. mg protein1. Sensi-
tivity to oligomycin (1 lg/ml) was tested in all mitochondrial
suspensions.
2.8. Determination of enzyme activity related to mitochondrial
respiratory chain (NADH and succinate dehydrogenase)
The activity of NADH and succinate dehydrogenases was mea-
sured spectrophotometrically according to Bracht et al. (2003),
using a DU-800 spectrophotometer (Beckman Coulter, Fullerton,
CA). The reaction medium (ﬁnal volume 1.5 ml) contained
20 mM TRIS, pH 7.4, and 1 lM Antimycin A. Disrupted mitochon-
dria (0.2 mg/ml) were added along with one of four abamectin con-
centrations (5, 10, 15 and 25 lM), either 1 mM NADH or 10 mM
succinate, and 0.4 mM potassium ferricyanide as electron acceptor.
The amount of ferricyanide reduced was determined by the de-
crease in absorbance at 420 nm and enzyme activity was repre-
sented as nmol. min1. mg protein1, using 1.04 mM1 as the
molar extinction coefﬁcient of ferricyanide.
2.9. Inhibition of ADP-induced depolarization of Dw
Inhibition of ADP-induced depolarization of Dw was performed
as described (O’Brien et al., 2008) with modiﬁcations. Freshly iso-
lated mitochondria were pre-incubated in the presence of 5–
25 lM ABA or 5 lM carboxyatractyloside (cATR) and then ener-
gized with 5 mM succinate for 1.5 min before adding 400 nmol
ADP. ADP-induced depolarization describes the change and recov-
ery in Dw upon addition of ADP. The amplitude of depolarization
induced by ADP was measured in the presence and absence of
the test compounds.
2.10. Statistical analysis
Data are expressed as the mean ± S.E. mean, and statistical dif-
ferences were calculated using one-way analysis of variance (ANO-
VA) followed by the Dunnett´s test using GraphPad Prism, v 4.0 for
Windows (GraphPad Software, San Diego, CA, USA).1 min
50
μm
o
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Fig. 3. Effect of abamectin (ABA, 25 lM) on CCCP-uncoupled (1 lM) respiration.
The ﬁgure is representative of three experiments with different mitochondrial
preparations. Arrows indicate addition of compounds. Oligo: oligomycin 1 lg/ml.
cATR: carboxyatractyloside 1 lM. KCN: potassium cyanide 1 lM. RFI: relative
ﬂuorescence intensity.3. Results
3.1. Effects of abamectin on mitochondrial respiration
Mitochondrial oxygen consumption was monitored in the pres-
ence of varying concentrations of ABA. The parameters assessed
were state-3 respiration (consumption of oxygen in the presence
of respiratory substrate and ADP) and state-4 respiration (con-
sumption of oxygen after ADP has been exhausted). At the concen-
trations tested (5–25 lM), ABA inhibited state-3 respiration of
mitochondria in a concentration-dependent manner. This effect
was observed when mitochondria were energized with either glu-
tamate plus malate, the respiratory chain site I substrates (Fig. 2A),
or succinate, a respiratory chain site II substrate (Fig. 2B). A maxi-
mum effect was observed at a concentration of 15 lM. ABA alsoinhibited state-3 respiration of TMPD plus ascorbate-energized
mitochondria in a concentration-dependent manner (data not
shown). The compound did not stimulate state-4 respiration, indi-
cating that it does not act as an uncoupler (data not shown).
Subsequent experiments with carbonyl cyanide m-chloro-
phenyl hydrazone (CCCP)-stimulated mitochondrial respiration
were performed to test the inhibitor effect of the compound on
the respiratory chain or on ATP synthase. ABA did not inhibit
CCCP-uncoupled respiration, indicating that only oxidative phos-
phorylation was inhibited (Fig. 3). The same behavior was ob-
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energized rat liver mitochondria. Assay conditions are described in Section 2.
Values represent the mean ± S.E. mean of three experiments with different
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side (ANT inhibitor).
3.2. Effect of abamectin on mitochondrial membrane potential (Dw)
Figure 4 shows the effect of ABA on the Dw of gluta-
mate + malate-energized rat liver mitochondria. ABA (25 lM) did
not dissipate Dw. The same behavior was observed for oligomycin
and carboxyatractyloside. At the end of the experiment, 1 lM CCCP
(uncoupler) or 2.5 lM rotenone (complex I inhibitor) was added as
a positive control, and the mitochondrial membrane electrical po-
tential dissipated.
3.3. Effect of abamectin on mitochondrial ATP levels
The effect of ABA on mitochondrial ATP levels was evaluated
using the respiratory assay conditions 15 min after mitochondria
were incubated with the compound (Fig. 5). In agreement with
the mitochondrial respiration results, ABA caused a signiﬁcant con-
centration-dependent decrease in mitochondrial ATP levels, reach-
ing a maximum effect at 15 lM.
3.4. Effects of abamectin on the FoF1-ATPase activity
The effects of ABA on FoF1-ATPase activity were measured in in-
tact-uncoupled mitochondria in the presence of CCCP, and in
freeze–thawing-disrupted mitochondria, as shown in Fig. 6A and
B, respectively. The ATPase activity of uncoupled mitochondria
was increased in a concentration-dependent manner by ABA
(Fig. 6A). In disrupted mitochondria, the effects were less dramatic
and similar across all concentrations tested (Fig. 6B).
3.5. Effect of abamectin on NADH and succinate dehydrogenase
activities
The effect of ABA on NADH and succinate dehydrogenase activ-
ity was measured in freeze–thawing-disrupted mitochondria. As
expected, ABA at concentrations from 5 to 25 lM did not cause sig-
niﬁcant changes in enzyme activity (data not shown).ABA,
cATR
or
Oligo
CCCP or Rot
10
0 
RF
I
1 min
Mit
Fig. 4. Effect of abamectin (ABA, 25 lM) on the membrane potential of glutamate
plus malate-energized rat liver mitochondria. Assay conditions are described in
Section 2. The ﬁgure is representative of three experiments with different
mitochondrial preparations. Arrows indicate addition of compounds. Mit: mito-
chondrial suspension 1 mg/ml. Oligo: oligomycin 1 lg/ml. cATR: carboxyatractylo-
side 1 lM. CCCP: CCCP 1 lM. Rot: rotenone 2.5 lM. RFI: relative ﬂuorescence
intensity.3.6. Effect of abamectin on ADP-induced depolarization of Dw
The purpose of this assay was to determine whether ABA inhib-
its ADP-induced depolarization of Dw by interference with ANT.
Carboxyatractyloside was used as a positive control for direct
ANT inhibition. ABA caused signiﬁcant, concentration-dependent
inhibition of ADP-stimulated depolarization of Dw (Fig. 7).4. Discussion
Mitochondrial dysfunction is a fundamental pathogenic mecha-
nism that leads to several signiﬁcant toxicities in mammals, espe-0
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Fig. 6. Effects of abamectin (ABA) on ATPase activity in intact-uncoupled mito-
chondria in the presence of CCCP (A) and in freeze–thawing-disrupted rat liver
mitochondria (B). Assay conditions are described in Section 2. Values represent the
mean ± S.E. mean of three experiments with different mitochondrial preparations.
C: control, only 0.1% DMSO. Oligo: oligomycin 1 lg/ml. ⁄,⁄⁄Signiﬁcantly different
from control (⁄P < 0.05 and ⁄⁄P < 0.01).
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Fig. 7. Effect of abamectin (ABA) on ADP-induced depolarization of Dw. Assay
conditions are described in Section 2. Values represent the mean ± S.E. mean of
three experiments with different mitochondrial preparations. C: control, only 0.1%
DMSO. cATR: carboxyatractyloside 5 lM. ⁄⁄Signiﬁcantly different from control
(P < 0.01).
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2002; Amacher, 2005). To assess the potential involvement of
mitochondria in ABA-related hepatotoxicity, we assessed its effects
on the bioenergetics of rat liver mitochondria. The results obtained
using mitochondria energized with glutamate + malate (electron
donors to complex I), succinate (electron donor to complex II)
and TMPD/ascorbate (artiﬁcial donor of electrons to complex IV)
showed that ABA inhibits state-3 respiration in a concentration-
dependent manner at concentrations from 5 to 25 lM. According
to Chance and Williams (1955), state-3 respiration involves mito-
chondria, ADP and a respiratory substrate, and the speed of ADP
phosphorylation is the limiting factor of the process. The inhibition
observed in the three experiments may result from the direct ac-
tion of abamectin on the respiratory chain, or from an inhibitory
effect on FoF1-ATPase or ANT.
It is possible to distinguish between inhibition of oxidative
phosphorylation and inhibition of the electron transport chain by
using an uncoupler-stimulated respiration test. If inhibition occurs
in electron transport chain, uncoupler-stimulated oxygen con-
sumption will be inhibited. If the tested compound instead acts
on the oxidative phosphorylation, it will be innocuous. We con-
ducted such a test using CCCP as an uncoupler and succinate as
the substrate. Mitochondrial oxygen consumption was not inhib-
ited by ABA but was inhibited for KCN (respiratory chain complex
IV inhibitor), indicating that the inhibition of state-3 respiration by
the compound does not occur through direct action on the respira-
tory chain. The effect is probably due to interaction with FoF1-ATP-
ase and/or the ADP/ATP translocator because it is similar to those
of oligomycin, a speciﬁc inhibitor of FoF1-ATPase, and carboxya-
tractyloside, an ANT inhibitor. In addition, mitochondrial oxygen
consumption inhibited by 25 lM ABA was further stimulated with
1 lM CCCP, demonstrating that the mitochondrial respiratory
chain was not inhibited (data not shown).
The complex I (NADH dehydrogenase) is the most vulnerable
complex of the electron transport chain. The smaller, simpler com-
plex II contains succinate dehydrogenase, the only enzyme of the
Krebs cycle linked to the inner mitochondrial membrane (Boelster-
li, 2007). We corroborated our results cited in the item 3.5 that saw
no ABA effect on NADH dehydrogenase and succinate
dehydrogenase.
ABA did not dissipate membrane potential, as do inhibitors of
respiratory chain complexes, such as rotenone and uncoupling
substances such as CCCP, i.e., those capable of acting on the linkage
between ATP synthesis and electron transport. Our results support
the hypothesis, proposed earlier, that ABA behaves similarly to oli-
gomycin and/or carboxyatractyloside, indicating that the toxicmechanism of ABA involves direct action on FoF1-ATPase and/or
ANT.
Because ATP is an essential metabolic component, interference
with its synthesis or use is the mechanism by which many xenobi-
otics express acute or chronic toxicity (Meyer and Kulkarni, 2001).
ABA signiﬁcantly inhibited the synthesis of ATP at 10 lM and
reached a maximum effect at 15 lM.
The ANT is an important component of the mitochondrial
machinery of ATP synthesis because of its intrinsic adenine nucle-
otide translocase activity. ANT participates in both pathological
(mitochondrial permeability transition formation/regulation and
cell death) and physiological (adenine nucleotide exchange) mito-
chondrial events, making it a prime target for drug-induced toxic-
ity (Oliveira and Wallace, 2006). To demonstrate ABA-induced
inhibition of ATPase and/or ANT, we evaluated its effects in the
activity of ATPase using intact-uncoupled and freeze–thawing-dis-
rupted mitochondria with an excess of ATP, a condition that drives
the enzyme to operate in the reverse direction, hydrolyzing ATP
(Bracht et al., 2003), and also in the ADP-induced depolarization
of Dw. We saw more signiﬁcant stimulation of ATPase activity in
intact-uncoupled mitochondria than in disrupted mitochondria,
which taken together with the observed inhibition of ADP-induced
depolarization of Dw indicates that abamectin more speciﬁcally
inhibits ANT than FoF1-ATPase.
In conclusion, the present study shows that ABA perturbs the
mitochondrial bioenergetics through different mechanisms and
that its effect on the adenine nucleotide translocator (ANT) is more
potent than on FoF1-ATPase. These effects constitute a potential
mechanism for ABA toxicity in liver cells, which could contribute
to the toxicological effects of ABA described in animals and human.
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